Corynebacterium striatum
Corynebacterium striatum is a species of bacteria that belongs to the genus Corynebacterium. It is a Gram-positive, non-spore-forming, and non-motile bacterium. It is known to cause a variety of infections in humans, particularly in those with compromised immune systems.
Characteristics[edit]
Corynebacterium striatum is a aerobic, Gram-positive bacterium. It is non-spore-forming and non-motile. The bacterium is rod-shaped and often forms V or L shapes due to the way it divides. It is catalase-positive and oxidase-negative.
Pathogenicity[edit]
Corynebacterium striatum is an opportunistic pathogen, meaning it typically causes infections in individuals with weakened immune systems. It has been associated with a variety of infections, including pneumonia, endocarditis, meningitis, and septic arthritis. The bacterium is often resistant to multiple antibiotics, making infections difficult to treat.
Treatment[edit]
Treatment of Corynebacterium striatum infections typically involves the use of antibiotics. However, the bacterium is often resistant to multiple antibiotics, making treatment challenging. In some cases, a combination of antibiotics may be used to effectively treat the infection.
Epidemiology[edit]
Corynebacterium striatum is found worldwide and can be isolated from a variety of sources, including soil, water, and human skin. It is often associated with hospital-acquired infections, particularly in individuals with compromised immune systems.
See also[edit]
-
Corynebacterium striatum on Columbia Horse Blood Agar
-
Corynebacterium striatum
-
Corynebacterium striatum
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
